Pharvaris NV (Pharvaris NV) ROE % Adjusted to Book Value : -9.44% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV ROE % Adjusted to Book Value?

Pharvaris NV's ROE % for the quarter that ended in Mar. 2024 was -30.11%. Pharvaris NV's PB Ratio for the quarter that ended in Mar. 2024 was 3.19. Pharvaris NV's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -9.44%.

Pharvaris NV ROE % Adjusted to Book Value Historical Data

The historical data trend for Pharvaris NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV ROE % Adjusted to Book Value Chart

Pharvaris NV Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-13.47

-17.22

-10.90

Pharvaris NV Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-33.20	0.59	-10.96	-14.02	-9.44

Competitive Comparison of Pharvaris NV's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Pharvaris NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharvaris NV's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharvaris NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pharvaris NV's ROE % Adjusted to Book Value falls into.

Pharvaris NV ROE % Adjusted to Book Value Calculation

Pharvaris NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-38.14%	/	3.50
	=	-10.90%

Pharvaris NV's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-30.11%	/	3.19
	=	-9.44%

Pharvaris NV ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharvaris NV (Pharvaris NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

9EN:Germany

Address

Emmy Noetherweg 2, Leiden, NLD, 2333 BK

Website

https://www.pharvaris.com

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.